(P61.9) Perinatal haematological disorder, unspecified

More details coming soon

Icon
325 367 in individuals diagnosis perinatal haematological disorder, unspecified confirmed
Icon
3 002 deaths with diagnosis perinatal haematological disorder, unspecified
Icon
1% mortality rate associated with the disease perinatal haematological disorder, unspecified

Diagnosis perinatal haematological disorder, unspecified is diagnosed Men are 12.21% more likely than Women

182 547

Men receive the diagnosis perinatal haematological disorder, unspecified

1 628 (0.9 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
142 820

Women receive the diagnosis perinatal haematological disorder, unspecified

1 374 (1.0 %)

Died from this diagnosis.

Risk Group for the Disease perinatal haematological disorder, unspecified - Men and Women aged 0

Icon
In Men diagnosis is most often set at age 0-5
Icon
Less common in men the disease occurs at Age 5-95+Less common in women the disease occurs at Age 5-29, 35-49, 55-95+
Icon
In Women diagnosis is most often set at age 0-5, 30-34, 50-54

Disease Features perinatal haematological disorder, unspecified

Icon
Absence or low individual and public risk
Icon

Perinatal haematological disorder, unspecified - what does this mean

Perinatal haematological disorder, unspecified is a disorder that affects the blood of a fetus or newborn baby. it is caused by abnormal red blood cells, platelets, or white blood cells that are present in the baby’s blood at birth. the exact cause is unknown, but it is thought to be related to genetic or environmental factors. it can lead to severe anemia, bleeding, and infections in the newborn. treatment may involve blood transfusions, antibiotics, and other medications.

What happens during the disease - perinatal haematological disorder, unspecified

Perinatal haematological disorder, unspecified is a disorder that affects the blood cells of infants, resulting in a decrease in the number of red blood cells, platelets, and/or white blood cells. this disorder can be caused by a variety of factors, such as genetic mutations, maternal infections, or environmental exposures. the exact cause of the disorder is difficult to determine due to the difficulty in identifying the underlying cause. however, the disorder can lead to anemia, thrombocytopenia, and/or leukopenia, which can cause a variety of symptoms.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete blood count (CBC) and peripheral smear
  • Clotting studies
  • Coagulation profile
  • Serum ferritin levels
  • Bone marrow examination
  • Liver function tests
  • Thyroid function tests
  • Urine analysis
  • Immunoglobulin levels
  • Genetic testing
  • Imaging studies (e.g. X-ray, ultrasound)

Treatment and Medical Assistance

Main goal of the treatment: To reduce the risk of mortality and morbidity associated with perinatal haematological disorder, unspecified.
  • Provide supportive care
  • Monitor vital signs
  • Administer antibiotics as needed
  • Provide nutritional support
  • Provide blood transfusions
  • Monitor for complications
  • Provide psychological support
  • Provide education to the patient and family
  • Monitor for signs of infection
  • Provide follow-up care
Icon
11 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Perinatal haematological disorder, unspecified - Prevention

Perinatal haematological disorder, unspecified can be prevented by ensuring pregnant women receive regular medical check-ups and prenatal care, including blood tests to monitor for any abnormalities. additionally, pregnant women should be aware of any family history of blood disorders and seek medical advice if they have any concerns.